Boothbay Fund Management, LLC Bio Restorative Therapies, Inc. Transaction History

Boothbay Fund Management, LLC

  • $3.6 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$2.58 - $3.68 $50,836 - $72,510
-19,704 Reduced 61.58%
12,296 $33,000
Q2 2022

Aug 15, 2022
SELL
$2.95 - $5.85 $23,600 - $46,800
-8,000 Reduced 20.0%
32,000 $94,000
Q1 2022

May 16, 2022
SELL
$3.3 - $5.69 $79,147 - $136,468
-23,984 Reduced 37.48%
40,000 $209,000
Q4 2021

Feb 14, 2022
BUY
$4.02 - $18.0 $257,215 - $1.15 Million
63,984 New
63,984 $278,000

Others Institutions Holding BRTX

# of Institutions
17
Shares Held
270K
Call Options Held
0
Put Options Held
0
View Full List

About BioRestorative Therapies, Inc.

BRTX Quotes by TradingView
  • Ticker BRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 3,650,030
  • Market Cap $5.62M
  • Description
  • BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtx...
More about BRTX
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email